Cornell University BIOG 1105-1106
Unit 5: Demos

Objective 1:

How inflammation works (interactive animation from Time magazine)
Immunology animation (optional)

Objective 9:

Complement system (9c) (much of this is supplemental)
Be the phagocyte!  Play the Immune System Defender Game
Immune response video (right click to download here or watch DVD in study center)
Immune response handout to accompany video

Objective 10:

The role of interleukins in the defensive response (10c)

Objective 11:

Booster shots and the role of memory cells (11b)
See optional links below for more information on vaccines and immunology
Poultry eggs may yield snake antivenin (optional)

Objective 12:

Autoimmune diseases result from a failure of "self-tolerance" (optional)
Multiple Sclerosis (optional)
Rethinking MS: multiple sclerosis may not be an autoimmune disease after all.
Lupus (optional)
Type-1 Diabetes (optional)
Publicly accessible MHC database for transplant / donor matching (optional)

Objective 13:

HIV and helper T cells
See optional links below for more information on HIV / AIDS

Objective 14:

What permits metastasis? (14b)
Scientific American: How Cancer Arises (available in Study Center; PDF available on Blackboard)

Objective 15:

Telomeres (15d)
Fix Those Genes or Else: defects in DNA proofreading can prompt tumors (optional)

Objective 16:

Scientific American: How Cancer Spreads (available in Study Center; PDF available on Blackboard)

Objective 17:

Risk factors for cancer
Immunotherapy for cancer (optional)
Learn more (from the American Cancer Society)
See optional links below for more information on cancer

Objective 18:

American Scientist: DNA Vaccines as Cancer Treatment (available in Study Center; PDF available on Blackboard)
HPV Vaccine: Info from the CDC
Cancer Vaccines (optional)
Scientific American: (available in Study Center; PDF available on Blackboard) (optional)

Telomeres and Telomerase

Every time a eucaryotic chromosome replicates, the new chromosomes thus formed lack a bit of DNA at each end. This occurs because DNA polymerase can only add nucleotides to the 3’ end. Recall from Unit 1 that both new strands are synthesized in the 5’ to 3’ direction, but the leading strand grows continuously while the lagging strand is produced in a short series of Okasaki fragments that are later joined by ligase. Replication must begin with an RNA primer at the 5’ end of the forming strand, so nucleotides can be added to the 3’ end of the primer. Later the RNA primers are removed. Those in the middle of the lagging strands can be filled after the primer is removed because there is DNA at the 5’ end to which nucleotides can join. But, there is no way to complete the 5’ ends of the daughter DNA strands, which means that each new chromosome has a gap at the 5’ end (see figure below). The ends of the chromosome have been clipped off. Repeated replications produce shorter and shorter chromosomes, and if a cell divides enough times, essential genetic material would be lost.

Prokaryotic chromosomes are circular, so there is always a DNA molecule to which a nucleotide can join and there is no problem. Eucaryotic cells, with their linear chromosomes, have solved the problem by having some moderately repetitive DNA sequences at the ends of their chromosomes. Called telomeres, these are multiple repetitions of a short nucleotide sequence (TTAGGG in humans). The number of repetitions in a telomere varies between 100 and 2500. Every time a cell divides the telomere shortens. If human cells are put into cell culture, they will continue to grow and divide for a while. But each chromosome may lose between 50 and 200 base pairs of telomeric DNA with each round of replication and division. This shortening interferes with the stability of the chromosomes, and after about 20-30 divisions most cells are no longer able to divide properly. The same thing happens to cells within the body; certain cells will divide for a fixed-number-of-divisions, and then no longer. Telomeres may therefore be a limiting factor in the life span of certain tissues, and the organism as a whole.

Certain cells within the body, notably the germ line cells and cells of the bone marrow, do maintain their telomeres despite repeated cycles of replication and division. How are they able to do so? Such cells have a special enzyme, called telomerase, which catalyzes the addition of lost telomeric segments. It is an unusual enzyme; it has a molecule of RNA in its active site; this sequence acts as a template for the addition of new telomeric sequences (.e., it acts like an RNA primer). Interestingly enough, researchers have found telomerase in more than 90 percent of human cancers. Telomerase appears to stabilize telomere length in cancer cells, enabling the cells to divide immortally. Since most normal cells do not have this activity, telomerase is an attractive target for both cancer diagnosis and drugs designed to attack tumors specifically.

© 2010 | BIOG 1105-1106